Wednesday, November 16, 2022

FDA Approves Omlonti (omidenepag isopropyl ophthalmic solution) for Reduction of Elevated Intraocular Pressure in Primary Open-Angle Glaucoma or Ocular Hypertension

›
Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and UBE Corporation (UBE)   announced   the U.S. Food and Drug...
Tuesday, November 15, 2022

FDA Approves Iheezo (chloroprocaine hydrochloride ophthalmic gel) for Ocular Surface Anesthesia

›
Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovat...
Monday, November 14, 2022

FDA Approves Relyvrio (sodium phenylbutyrate/taurursodiol) for Patients with Amyotrophic Lateral Sclerosis (ALS)

›
In continuation of my update on phenyl butyrate and taurursodiol .. Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”)...
Saturday, November 12, 2022

FDA Approves Lytgobi (futibatinib) for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

›
Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved  Lytgo...
Friday, November 11, 2022

FDA Approves Furoscix (furosemide injection) for the At-Home Treatment of Congestion Due to Fluid Overload in Chronic Heart Failure

›
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential t...
Tuesday, October 11, 2022

BioLineRx Announces Submission of New Drug Application (NDA) to FDA for Motixafortide in Stem Cell Mobilization

›
BioLineRx Ltd.  announced the  submission of  its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Motixafortid...
Monday, October 10, 2022

Cidara Therapeutics Announces FDA Acceptance for Priority Review of New Drug Application for Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

›
Cidara Therapeutics, Inc.  , a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patien...
Friday, October 7, 2022

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

›
The researchers developed three different computer models to predict how a hypothetical set of 10,000 patients with specific types of metast...
Thursday, October 6, 2022

Drug turns cancer gene into 'eat me' flag for immune system

›
Sotorasib The new therapy, described Sept. 12 in  Cell Cancer , pulls a mutated version of the protein KRAS to the surface of cancer cells, ...
Wednesday, October 5, 2022

Smoking May Increase Odds of Meniere Disease in Men

›
For men, smoking is positively related and alcohol consumption is negatively related to the risk for Meniere disease (MD), according to a st...
Tuesday, October 4, 2022

Daily Multivitamin May Protect Against Cognitive Decline in Older Adults

›
In continuation of my update on Vitamin and their importance  A daily multivitamin may provide cognitive benefits for older adults, accordi...
Monday, October 3, 2022

FDA Approves Zoryve (roflumilast) Cream for the Treatment of Plaque Psoriasis

›
      Arcutis Biotherapeutics, Inc.   an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...
Friday, September 30, 2022

FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults

›
            dextromethorphan   Bupropion In continuation of my updates on dextromethorphan and Bupropion ,  Axsome Therapeutics, Inc. , a...
Thursday, September 29, 2022

FDA Approves Konvomep (omeprazole and sodium bicarbonate for oral suspension) for Gastric Ulcer and Reduction of Risk of Gastrointestinal Bleeding in Critically Ill Patients

›
     In continuation of my update on omeprazole Azurity Pharmaceuticals, Inc., a pharmaceutical company focused on developing innovative do...